Home › Funds › CANNELL CAPITAL LLC › VRCA

CANNELL CAPITAL LLC position in VRCA

VERRICA PHARMACEUTICALS INC · Health Care

CANNELL CAPITAL LLC reported holding 783,923 shares of VRCA (VERRICA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$4.8M, representing 3.39% of its reported portfolio and ranking #15 among its reported holdings. CANNELL CAPITAL LLC has disclosed VRCA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)783.92K sh
Reported value held$4.80M
Portfolio Weight3.39%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CANNELL CAPITAL LLC's VRCA position evolved

CANNELL CAPITAL LLC first disclosed a stake in VRCA in Q1 2026 at 685,123 shares (US$3.6M). The position peaked in Q2 2026 at 783,923 shares, worth US$4.8M. Across 2 filings, CANNELL CAPITAL LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 783,923 shares valued at US$4.8M — an increase of 98,800 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 685.12K $3.62M New
Q2 2026 783.92K $4.80M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRCA and 13F data

VRCA (VERRICA PHARMACEUTICALS INC) is a Health Care company. 20 other funds we track also report a position in VRCA — the largest reported positions include Caligan Partners LP (US$5.7M), Velan Capital Investment Management LP (US$2.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRCA

All VRCA fund holders →

FAQ

How long has CANNELL CAPITAL LLC held VRCA?

CANNELL CAPITAL LLC has disclosed VRCA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is CANNELL CAPITAL LLC's current position in VRCA?

As of Q2 2026, CANNELL CAPITAL LLC holds 783.92K shares of VRCA (VERRICA PHARMACEUTICALS INC), valued at $4.80M, representing 3.39% of its reported portfolio and ranking #15.

Has CANNELL CAPITAL LLC been buying or selling VRCA?

In the latest 13F filing (Q2 2026), CANNELL CAPITAL LLC increased its position in VRCA. The position peaked in Q2 2026 at 783.92K shares.

Which other funds hold VRCA?

Other major institutional holders of VRCA include Caligan Partners LP, Velan Capital Investment Management LP, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.